Filing Details

Accession Number:
0001415889-24-006846
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-03-05 18:22:37
Reporting Period:
2024-03-01
Accepted Time:
2024-03-05 18:22:37
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1127537 Pulmonx Corp LUNG Surgical & Medical Instruments & Apparatus (3841) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1804146 Beran Geoffrey Rose C/O Pulmonx Corporation
700 Chesapeake Drive
Redwood City CA 94063
Chief Commercial Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-03-01 428 $9.06 242,621 No 4 S Direct
Common Stock Disposition 2024-03-01 753 $9.06 241,868 No 4 S Direct
Common Stock Disposition 2024-03-01 1,916 $9.06 239,952 No 4 S Direct
Common Stock Acquisiton 2024-03-01 34,500 $0.00 274,452 No 4 A Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 A Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Acquisiton 2024-03-01 69,100 $0.00 69,100 $9.30
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
69,100 2034-02-28 No 4 A Direct
Footnotes
  1. These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units (the "RSUs") granted on June 1, 2021.
  2. These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2022.
  3. These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2023.
  4. Represents grant of RSUs payable solely in common stock of the Issuer that vest over four years in equal quarterly installments beginning on March 1, 2024.
  5. The shares subject to the option vest in 48 equal monthly installments beginning on March 1, 2024.